| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
79,620,000 |
| Market
Cap: |
12.77(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.1604 - $0.1604 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Soleno Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare diseases. Co.'s primary candidate is Diazoxide Choline Extended Release tablets (DCCR), a once-daily oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
178,298 |
343,298 |
| Total Buy Value |
$0 |
$0 |
$1,041,856 |
$1,897,756 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
6 |
12 |
| Total Shares Sold |
1,129,833 |
1,383,088 |
1,419,857 |
2,030,451 |
| Total Sell Value |
$52,883,521 |
$61,477,256 |
$62,474,611 |
$63,437,018 |
| Total People Sold |
5 |
5 |
5 |
6 |
| Total Sell Transactions |
6 |
23 |
27 |
76 |
| End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Engleman Edgar |
Director |
– • • |
2016-01-08 |
4 |
A |
$0.00 |
$0 |
I/I |
333,787 |
79,653 |
|
- |
|
| Vivo Ventures V Affiliates Fund, L.p. |
10% Owner |
– – • |
2015-11-19 |
4 |
A |
$0.00 |
$0 |
I/I |
1,643,309 |
75,781 |
|
- |
|
| Engleman Edgar |
Director |
– • • |
2015-11-19 |
4 |
A |
$0.00 |
$0 |
I/I |
1,643,309 |
75,781 |
|
- |
|
| Mario Ernest |
Director |
– • • |
2015-11-18 |
4 |
B |
$1.77 |
$88,500 |
D/D |
50,000 |
1,639,831 |
3.92 |
- |
|
| Otoole David D |
SVP & Chief Financial Officer |
• – – |
2015-11-17 |
4 |
B |
$1.79 |
$8,950 |
D/D |
5,000 |
27,750 |
2.74 |
- |
|
| Mario Ernest |
Director |
– • • |
2015-09-14 |
4 |
B |
$2.28 |
$34,200 |
D/D |
15,000 |
1,589,831 |
3.92 |
- |
|
| Otoole David D |
SVP & Chief Financial Officer |
• – – |
2015-09-14 |
4 |
B |
$2.38 |
$17,885 |
D/D |
7,500 |
22,750 |
2.74 |
- |
|
| Mario Ernest |
Director |
– • • |
2015-08-21 |
4 |
B |
$1.91 |
$30,995 |
D/D |
16,228 |
1,553,999 |
3.92 |
- |
|
| Mario Ernest |
Director |
– • • |
2015-08-18 |
4/A |
A |
$0.00 |
$0 |
D/D |
210,251 |
1,537,771 |
|
- |
|
| Vivo Ventures V Affiliates Fund, L.p. |
10% Owner |
– – • |
2015-08-14 |
4 |
A |
$0.00 |
$0 |
I/I |
1,051,254 |
56,722 |
|
- |
|
| Engleman Edgar |
Director |
– • • |
2015-08-14 |
4 |
A |
$0.00 |
$0 |
I/I |
1,051,254 |
56,722 |
|
- |
|
| Vivo Ventures V Affiliates Fund, L.p. |
10% Owner |
– – • |
2015-08-12 |
4 |
A |
$0.00 |
$0 |
I/I |
796,464 |
44,527 |
|
- |
|
| Engleman Edgar |
Director |
– • • |
2015-08-12 |
4 |
A |
$0.00 |
$0 |
I/I |
796,464 |
44,527 |
|
- |
|
| Anish Bhatnagar |
See Remarks |
• • – |
2015-08-12 |
4 |
B |
$1.64 |
$16,400 |
D/D |
10,000 |
10,000 |
2.81 |
- |
|
| Mario Ernest |
Director |
– • • |
2015-08-12 |
4 |
B |
$1.64 |
$16,440 |
D/D |
10,000 |
1,327,520 |
3.92 |
- |
|
| Mario Ernest |
Director |
– • • |
2015-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
210,251 |
1,477,771 |
|
- |
|
| Otoole David D |
See Remarks |
• – – |
2015-08-11 |
4 |
B |
$1.78 |
$17,800 |
D/D |
10,000 |
15,250 |
2.74 |
- |
|
| Mario Ernest |
Director |
– • • |
2015-08-11 |
4 |
B |
$1.77 |
$88,500 |
D/D |
50,000 |
1,317,520 |
3.92 |
- |
|
| Mario Ernest |
Director |
– • • |
2015-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
786,645 |
1,267,520 |
|
- |
|
| Mario Ernest |
Director |
– • • |
2015-06-25 |
4 |
OE |
$3.48 |
$191,397 |
D/D |
54,999 |
480,875 |
|
- |
|
| Mario Ernest |
Director |
– • • |
2015-06-04 |
4 |
OE |
$3.48 |
$87,000 |
D/D |
25,000 |
425,876 |
|
- |
|
| Otoole David D |
Chief Financial Officer |
• – – |
2015-03-13 |
4 |
B |
$6.23 |
$32,708 |
D/D |
5,250 |
5,250 |
2.74 |
- |
|
| Engelsen Steinar J |
Director |
– • – |
2014-11-18 |
4 |
S |
$0.00 |
$0 |
D/D |
(15,007) |
0 |
|
- |
|
| Engelsen Steinar J |
Director |
– • – |
2014-11-18 |
4 |
B |
$0.00 |
$0 |
D/D |
3,111 |
3,850 |
2.31 |
- |
|
| Engelsen Steinar J |
Director |
– • – |
2014-11-18 |
4 |
A |
$0.00 |
$0 |
D/D |
696 |
739 |
|
- |
|
386 Records found
|
|
Page 15 of 16 |
|
|
